Treatment of ulcerative colitis by feeding with germinated barley foodstuff: first report of a multicenter open control trial
- First Online:
- 240 Downloads
Background. Germinated barley foodstuff (GBF) is a prebiotic foodstuff that effectively increases luminal butyrate production by stimulating the growth of protective bacteria. In the first pilot study, GBF has been shown to reduce both clinical activity and mucosal inflammation in ulcerative colitis (UC). The aim of this study was to investigate the efficacy of GBF in the treatment of UC in a multicenter open control trial. Methods. Eighteen patients with mildly to moderately active UC were divided into two groups using a random allocation protocol. The control group (n = 7) were given a baseline anti-inflammatory therapy for 4 weeks. In the GBF-treated group (n = 11), patients received 20–30 g GBF daily, together with the baseline treatment, for 4 weeks. The response to the treatments was evaluated clinically and endoscopically. Fecal micro-flora were also analyzed. Results. After 4 weeks of observation, the GBF-treated group showed a significant decrease in clinical activity index scores compared with the control group (P < 0.05). No side effects related to GBF were observed. GBF therapy increased fecal concentrations of Bifidobacterium and Eubacterium limosum. Conclusions. Oral GBF therapy may have the potency to reduce clinical activity of UC. We believe that these results support the use of GBF administration as a new adjunct therapy for UC.
Keywordsprebiotics probiotic ulcerative colitis microflora
Unable to display preview. Download preview PDF.
- 4.Venturi A, Gionchetti P, Rizzello F, Johansson R, Zucconi E, Brigidi P, et al. Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis. Aliment Pharmacol Ther 1999;13:1103–8.PubMedCrossRefGoogle Scholar
- 7.Sartor RB. Microbial factors in the pathogenesis of Crohn’s disease, ulcerative colitis, and experimental intestinal inflammation. In: Kirsner JB, Shorter RG, editors. Inflammatory bowel disease. 4th ed. Baltimore: Williams and Wilkins; 1995. p. 96–124.Google Scholar
- 10.Fernandez BF, Hinojosa J, Sanchez LJL, Navarro E, Martinez SJF, Garcias PA, et al. Randomized clinical trial of Plantago ovata seeds (dietary fiber) as compared with mesalamine in maintaining remission in ulcerative colitis. Spanish Group for the study of Crohn’s disease and ulcerative colitis (GETECCU). Am J Gastroenterol 1999;94:427–33.Google Scholar
- 12.Roediger WE. The colonic epithelium in ulcerative colitis: an energy-deficiency disease? Lancet 980;2:712–15.Google Scholar
- 21.Kanauchi O, Iwanaga T, Andoh A, Araki Y, Nakamura T, Mitsuyama K, et al. Dietary fiber fraction of germinated barley foodstuff attenuated mucosal damage and diarrhea, and accelerated the repair of the colonic mucosa in an experimental colitis. J Gastroenterol Hepatol 2001;16:160–8.PubMedCrossRefGoogle Scholar
- 28.Kanauchi O, Andoh A, Iwanaga T, Fujiyama Y, Mitsuyama K, Toyonaga A, et al. Germinated barley foodstuffs attenuate co-Ionic mucosal damage and mucosal nuclear factor kappa B activity in a spontaneous colitis model in HLA-B27 transgenic rats. J Gastroenterol Hepatol 1999;14:1173–9.PubMedCrossRefGoogle Scholar